Activation	O
of	O
the	O
orphan	B:C2002138
receptor	I:C2002138
GPR55	I:C2002138
by	O
lysophosphatidylinositol	O
promotes	O
metastasis	O
in	O
triple	O
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878

Activation	O
of	O
the	O
orphan	O
receptor	I:C2002138
GPR55	I:C2002138
by	O
lysophosphatidylinositol	B:C0065391
promotes	O
metastasis	O
in	O
triple	O
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878

Activation	O
of	O
the	O
orphan	O
receptor	I:C2002138
GPR55	I:C2002138
by	O
lysophosphatidylinositol	O
promotes	O
metastasis	B:C0027627
in	O
triple	O
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878

Activation	O
of	O
the	O
orphan	O
receptor	I:C2002138
GPR55	I:C2002138
by	O
lysophosphatidylinositol	O
promotes	O
metastasis	O
in	O
triple	B:C3539878
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878

The	O
orphan	B:C0682972
G	I:C0682972
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
GPR55	O
has	O
been	O
directly	O
or	O
indirectly	O
related	O
to	O
basic	O
alterations	O
that	O
drive	O
malignant	O
growth	O
:	O
uncontrolled	O
cancer	O
cell	O
proliferation	I:C0596290
,	O
sustained	O
angiogenesis	I:C0302600
,	O
and	O
cancer	O
cell	O
adhesion	I:C0007577
and	O
migration	O
.	O

The	O
orphan	O
G	I:C0682972
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
GPR55	B:C2002138
has	O
been	O
directly	O
or	O
indirectly	O
related	O
to	O
basic	O
alterations	O
that	O
drive	O
malignant	O
growth	O
:	O
uncontrolled	O
cancer	O
cell	O
proliferation	I:C0596290
,	O
sustained	O
angiogenesis	I:C0302600
,	O
and	O
cancer	O
cell	O
adhesion	I:C0007577
and	O
migration	O
.	O

The	O
orphan	O
G	I:C0682972
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
GPR55	O
has	O
been	O
directly	O
or	O
indirectly	O
related	O
to	O
basic	O
alterations	O
that	O
drive	O
malignant	O
growth	B:C0018270
:	O
uncontrolled	O
cancer	O
cell	O
proliferation	I:C0596290
,	O
sustained	O
angiogenesis	I:C0302600
,	O
and	O
cancer	O
cell	O
adhesion	I:C0007577
and	O
migration	O
.	O

The	O
orphan	O
G	I:C0682972
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
GPR55	O
has	O
been	O
directly	O
or	O
indirectly	O
related	O
to	O
basic	O
alterations	O
that	O
drive	O
malignant	O
growth	O
:	O
uncontrolled	O
cancer	O
cell	B:C0596290
proliferation	I:C0596290
,	O
sustained	O
angiogenesis	I:C0302600
,	O
and	O
cancer	O
cell	O
adhesion	I:C0007577
and	O
migration	O
.	O

The	O
orphan	O
G	I:C0682972
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
GPR55	O
has	O
been	O
directly	O
or	O
indirectly	O
related	O
to	O
basic	O
alterations	O
that	O
drive	O
malignant	O
growth	O
:	O
uncontrolled	O
cancer	O
cell	O
proliferation	I:C0596290
,	O
sustained	B:C0302600
angiogenesis	I:C0302600
,	O
and	O
cancer	O
cell	O
adhesion	I:C0007577
and	O
migration	O
.	O

The	O
orphan	O
G	I:C0682972
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
GPR55	O
has	O
been	O
directly	O
or	O
indirectly	O
related	O
to	O
basic	O
alterations	O
that	O
drive	O
malignant	O
growth	O
:	O
uncontrolled	O
cancer	O
cell	O
proliferation	I:C0596290
,	O
sustained	O
angiogenesis	I:C0302600
,	O
and	O
cancer	O
cell	B:C0007577
adhesion	I:C0007577
and	O
migration	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
involvement	O
of	O
this	O
receptor	B:C0597357
in	O
metastasis	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
involvement	O
of	O
this	O
receptor	O
in	O
metastasis	B:C0027627
.	O

Here	O
,	O
we	O
show	O
that	O
elevated	O
GPR55	O
expression	O
in	O
human	B:C0086418
tumors	O
is	O
associated	O
with	O
the	O
aggressive	O
basal	I:C0027671
/	O
triple	O
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878
population	O
,	O
higher	O
probability	O
to	O
develop	O
metastases	O
,	O
and	O
therefore	O
poor	O
patient	O
prognosis	O
.	O

Here	O
,	O
we	O
show	O
that	O
elevated	O
GPR55	O
expression	O
in	O
human	O
tumors	B:C0027651
is	O
associated	O
with	O
the	O
aggressive	O
basal	I:C0027671
/	O
triple	O
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878
population	O
,	O
higher	O
probability	O
to	O
develop	O
metastases	O
,	O
and	O
therefore	O
poor	O
patient	O
prognosis	O
.	O

Here	O
,	O
we	O
show	O
that	O
elevated	O
GPR55	O
expression	O
in	O
human	O
tumors	O
is	O
associated	O
with	O
the	O
aggressive	B:C0027671
basal	I:C0027671
/	O
triple	O
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878
population	O
,	O
higher	O
probability	O
to	O
develop	O
metastases	O
,	O
and	O
therefore	O
poor	O
patient	O
prognosis	O
.	O

Here	O
,	O
we	O
show	O
that	O
elevated	O
GPR55	O
expression	O
in	O
human	O
tumors	O
is	O
associated	O
with	O
the	O
aggressive	O
basal	I:C0027671
/	O
triple	B:C3539878
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878
population	O
,	O
higher	O
probability	O
to	O
develop	O
metastases	O
,	O
and	O
therefore	O
poor	O
patient	O
prognosis	O
.	O

Here	O
,	O
we	O
show	O
that	O
elevated	O
GPR55	O
expression	O
in	O
human	O
tumors	O
is	O
associated	O
with	O
the	O
aggressive	O
basal	I:C0027671
/	O
triple	O
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878
population	B:C1257890
,	O
higher	O
probability	O
to	O
develop	O
metastases	O
,	O
and	O
therefore	O
poor	O
patient	O
prognosis	O
.	O

Here	O
,	O
we	O
show	O
that	O
elevated	O
GPR55	O
expression	O
in	O
human	O
tumors	O
is	O
associated	O
with	O
the	O
aggressive	O
basal	I:C0027671
/	O
triple	O
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878
population	O
,	O
higher	O
probability	O
to	O
develop	O
metastases	B:C0027627
,	O
and	O
therefore	O
poor	O
patient	O
prognosis	O
.	O

Here	O
,	O
we	O
show	O
that	O
elevated	O
GPR55	O
expression	O
in	O
human	O
tumors	O
is	O
associated	O
with	O
the	O
aggressive	O
basal	I:C0027671
/	O
triple	O
-	I:C3539878
negative	I:C3539878
breast	I:C3539878
cancer	I:C3539878
population	O
,	O
higher	O
probability	O
to	O
develop	O
metastases	O
,	O
and	O
therefore	O
poor	O
patient	O
prognosis	B:C0033325
.	O

Activation	O
of	O
GPR55	B:C2002138
by	O
its	O
proposed	O
endogenous	O
ligand	O
lysophosphatidylinositol	O
confers	O
pro-invasive	O
features	O
on	O
breast	O
cancer	I:C1512505
cells	I:C1512505
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Activation	O
of	O
GPR55	O
by	O
its	O
proposed	O
endogenous	O
ligand	B:C0023688
lysophosphatidylinositol	O
confers	O
pro-invasive	O
features	O
on	O
breast	O
cancer	I:C1512505
cells	I:C1512505
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Activation	O
of	O
GPR55	O
by	O
its	O
proposed	O
endogenous	O
ligand	O
lysophosphatidylinositol	B:C0065391
confers	O
pro-invasive	O
features	O
on	O
breast	O
cancer	I:C1512505
cells	I:C1512505
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Activation	O
of	O
GPR55	O
by	O
its	O
proposed	O
endogenous	O
ligand	O
lysophosphatidylinositol	O
confers	O
pro-invasive	O
features	O
on	O
breast	B:C1512505
cancer	I:C1512505
cells	I:C1512505
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Activation	O
of	O
GPR55	O
by	O
its	O
proposed	O
endogenous	O
ligand	O
lysophosphatidylinositol	O
confers	O
pro-invasive	O
features	O
on	O
breast	O
cancer	I:C1512505
cells	I:C1512505
both	O
in	O
vitro	O
and	O
in	B:C1515655
vivo	I:C1515655
.	O

Specifically	O
,	O
this	O
effect	O
is	O
elicited	O
by	O
coupling	O
to	O
Gq	B:C2975447
/	I:C2975447
11	I:C2975447
heterotrimeric	I:C2975447
proteins	I:C2975447
and	O
the	O
subsequent	O
activation	O
,	O
through	O
ERK	O
,	O
of	O
the	O
transcription	O
factor	I:C1333479
ETV4	I:C1333479
/	O
PEA3	O
.	O

Specifically	O
,	O
this	O
effect	O
is	O
elicited	O
by	O
coupling	O
to	O
Gq	O
/	I:C2975447
11	I:C2975447
heterotrimeric	I:C2975447
proteins	I:C2975447
and	O
the	O
subsequent	O
activation	O
,	O
through	O
ERK	B:C0600388
,	O
of	O
the	O
transcription	O
factor	I:C1333479
ETV4	I:C1333479
/	O
PEA3	O
.	O

Specifically	O
,	O
this	O
effect	O
is	O
elicited	O
by	O
coupling	O
to	O
Gq	O
/	I:C2975447
11	I:C2975447
heterotrimeric	I:C2975447
proteins	I:C2975447
and	O
the	O
subsequent	O
activation	O
,	O
through	O
ERK	O
,	O
of	O
the	O
transcription	B:C1333479
factor	I:C1333479
ETV4	I:C1333479
/	O
PEA3	O
.	O

Specifically	O
,	O
this	O
effect	O
is	O
elicited	O
by	O
coupling	O
to	O
Gq	O
/	I:C2975447
11	I:C2975447
heterotrimeric	I:C2975447
proteins	I:C2975447
and	O
the	O
subsequent	O
activation	O
,	O
through	O
ERK	O
,	O
of	O
the	O
transcription	O
factor	I:C1333479
ETV4	I:C1333479
/	O
PEA3	B:C0084827
.	O

Together	O
,	O
these	O
data	O
show	O
that	O
GPR55	B:C2002138
promotes	O
breast	O
cancer	I:C0678222
metastasis	O
,	O
and	O
supports	O
the	O
notion	O
that	O
this	O
orphan	O
receptor	I:C0597357
may	O
constitute	O
a	O
new	O
therapeutic	O
target	O
and	O
potential	O
biomarker	O
in	O
the	O
highly	O
aggressive	O
triple	I:C1519691
-	I:C1519691
negative	I:C1519691
subtype	I:C1519691
.	O

Together	O
,	O
these	O
data	O
show	O
that	O
GPR55	O
promotes	O
breast	B:C0678222
cancer	I:C0678222
metastasis	O
,	O
and	O
supports	O
the	O
notion	O
that	O
this	O
orphan	O
receptor	I:C0597357
may	O
constitute	O
a	O
new	O
therapeutic	O
target	O
and	O
potential	O
biomarker	O
in	O
the	O
highly	O
aggressive	O
triple	I:C1519691
-	I:C1519691
negative	I:C1519691
subtype	I:C1519691
.	O

Together	O
,	O
these	O
data	O
show	O
that	O
GPR55	O
promotes	O
breast	O
cancer	I:C0678222
metastasis	B:C0027627
,	O
and	O
supports	O
the	O
notion	O
that	O
this	O
orphan	O
receptor	I:C0597357
may	O
constitute	O
a	O
new	O
therapeutic	O
target	O
and	O
potential	O
biomarker	O
in	O
the	O
highly	O
aggressive	O
triple	I:C1519691
-	I:C1519691
negative	I:C1519691
subtype	I:C1519691
.	O

Together	O
,	O
these	O
data	O
show	O
that	O
GPR55	O
promotes	O
breast	O
cancer	I:C0678222
metastasis	O
,	O
and	O
supports	O
the	O
notion	O
that	O
this	O
orphan	B:C0597357
receptor	I:C0597357
may	O
constitute	O
a	O
new	O
therapeutic	O
target	O
and	O
potential	O
biomarker	O
in	O
the	O
highly	O
aggressive	O
triple	I:C1519691
-	I:C1519691
negative	I:C1519691
subtype	I:C1519691
.	O

Together	O
,	O
these	O
data	O
show	O
that	O
GPR55	O
promotes	O
breast	O
cancer	I:C0678222
metastasis	O
,	O
and	O
supports	O
the	O
notion	O
that	O
this	O
orphan	O
receptor	I:C0597357
may	O
constitute	O
a	O
new	O
therapeutic	O
target	O
and	O
potential	O
biomarker	B:C0005516
in	O
the	O
highly	O
aggressive	O
triple	I:C1519691
-	I:C1519691
negative	I:C1519691
subtype	I:C1519691
.	O

Together	O
,	O
these	O
data	O
show	O
that	O
GPR55	O
promotes	O
breast	O
cancer	I:C0678222
metastasis	O
,	O
and	O
supports	O
the	O
notion	O
that	O
this	O
orphan	O
receptor	I:C0597357
may	O
constitute	O
a	O
new	O
therapeutic	O
target	O
and	O
potential	O
biomarker	O
in	O
the	O
highly	O
aggressive	B:C1519691
triple	I:C1519691
-	I:C1519691
negative	I:C1519691
subtype	I:C1519691
.	O

